Larimar Therapeutics
LRMR
#7761
Rank
A$0.40 B
Marketcap
$6.41
Share price
0.75%
Change (1 day)
1.94%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.39

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.47. In 2022 the company made an earnings per share (EPS) of -$2.46 an increase over its 2021 EPS that were of -$4.75.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.39-43.7%
2022-$2.46-48.15%
2021-$4.75-14.27%
2020-$5.54